Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
247 studies found for:    "metatropic dysplasia" OR "Dwarfism"
Show Display Options
RSS Create an RSS feed from your search for:
"metatropic dysplasia" OR "Dwarfism"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Role of Nutrition and Hormones in Boys With Disordered Growth
Conditions: Short Stature;   Constitutional Delay of Growth and Development;   Dwarfism, Pituitary
Intervention: Drug: Growth Hormone Therapy
2 Completed A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
Conditions: Dwarfism;   Growth Hormone Deficiency
Intervention: Drug: r-hGH
3 Active, not recruiting Observational Study of Somatropin Treatment in Children
Conditions: Dwarfism, Growth Hormone Deficiency;   Turner Syndrome;   Infant, Small for Gestational Age;   SHOX Protein, Human
Intervention: Drug: Somatropin (rDNA origin)
4 Completed
Has Results
Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®
Condition: Dwarfism, Pituitary
Intervention: Drug: Recombinant human growth hormone (r-hGH)
5 Completed Study of Skeletal Disorders and Short Stature
Conditions: Developmental Bone Disease;   Dwarfism;   Skeletal Dysplasias
Intervention:
6 Not yet recruiting The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature
Condition: Short Stature
Intervention: Drug: Growth Hormone
7 Recruiting Short Stature Related Distress
Conditions: Idiopathic Short Stature;   Self Image
Interventions: Drug: GH treatment (Genotropin);   Drug: 1 year treatment with placebo followed by optional 3 years of GH treatment
8 Terminated Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature
Conditions: Turner Syndrome;   Idiopathic Short Stature
Intervention: Drug: somatropin (rDNA)
9 Active, not recruiting A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)
Condition: Idiopathic Short Stature
Intervention: Drug: Saizen®
10 Completed rhGH Therapy on Hepatic Drug Metabolism
Condition: Growth Hormone Deficiency, Dwarfism
Intervention: Drug: Dextromethorphan and Caffeine
11 Completed Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
Conditions: Dwarfism, Pituitary;   Turner Syndrome
Intervention:
12 Completed National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
Condition: Dwarfism, Pituitary
Intervention:
13 Recruiting Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
Condition: Dwarfism, Pituitary
Intervention: Biological: PEG-somatropin
14 Completed
Has Results
Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency
Conditions: Childhood-onset Growth Hormone Deficiency;   Pituitary Dwarfism
Intervention: Biological: recombinant human growth hormone
15 Active, not recruiting Idiopathic Short Stature Study
Condition: Idiopathic Short Stature
Intervention: Drug: DA-3002
16 Not yet recruiting PREPL in Health and Disease
Conditions: Hypotonia-Cystinuria Syndrome;   Muscle Hypotonia;   Healthy Volunteers;   Dwarfism, Growth Hormone Deficiency;   Obesity;   Prader-Willi Syndrome
Interventions: Procedure: Blood draw;   Procedure: muscle biopsy
17 Completed
Has Results
Drug Use Investigation of Somatropin for GHD-ADULTS.
Condition: Dwarfism, Growth Hormone Deficiency
Intervention: Drug: Somatropin
18 Completed Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
Condition: Idiopathic Short Stature
Intervention: Drug: Somatotropin growth hormone recombinant human
19 Completed
Has Results
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
Condition: Idiopathic Short Stature
Intervention: Drug: Genotropin
20 Active, not recruiting Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature
Condition: Idiopathic Short Stature
Interventions: Drug: Aromatase Inhibitor;   Drug: Growth Hormone;   Drug: Aromatase Inhibitor and Growth Hormone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years